 |
|
Efficacy of Primary Intravitreal Ranibizumab Injection for Treatment of Type 1 Retinopathy of Prematurity.
Gyu Chul Chung, Sung Hyuk Moon
J Korean Ophthalmol Soc. 2017;58(9):1080-1086. Published online 2017 Sep 15 DOI: https://doi.org/10.3341/jkos.2017.58.9.1080
|
|
Citations to this article as recorded by
 Comparison of Intravitreal Bevacizumab and Ranibizumab Injections in Aggressive and Type 1 Retinopathy of Prematurity
Kyumin Kang, Ji Hye Jang
Journal of the Korean Ophthalmological Society.2023; 64(9): 784. CrossRef Predictive Factors for Retreatment after Intravitreal Ranibizumab Injection to Treat Type 1 Retinopathy of Prematurity
Su Hwan Park, Iksoo Byon, Han Jo Kwon
Journal of the Korean Ophthalmological Society.2023; 64(9): 793. CrossRef
|